No abstract available
Keywords:
Cardiovascular disease; Chronic kidney disease; GLP-1 receptor agonist; Heart failure; SGLT2 inhibitor; Type 2 diabetes.
MeSH terms
-
Cardiologists / organization & administration*
-
Clinical Trials as Topic / methods
-
Clinical Trials as Topic / organization & administration
-
Cooperative Behavior
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / economics
-
Diabetes Mellitus, Type 2 / mortality
-
Diabetes Mellitus, Type 2 / therapy*
-
Diabetic Angiopathies / economics
-
Diabetic Angiopathies / mortality
-
Diabetic Angiopathies / prevention & control
-
Diabetic Angiopathies / therapy*
-
Endocrinologists / organization & administration*
-
Health Care Costs
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Interdisciplinary Communication
-
Patient Care Team / organization & administration*
-
Preventive Medicine
-
Research Design
-
Risk Factors